Production (Stage)
bluebird bio, Inc.
BLUE
$4.97
-$0.01-0.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 58.36% | 64.48% | 30.29% | -29.63% | -468.75% |
| Total Depreciation and Amortization | 0.48% | 56.85% | 107.07% | 171.90% | 150.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 56.36% | -41.80% | -66.47% | -0.62% | 112.01% |
| Change in Net Operating Assets | -49.95% | -1,632.63% | -363.16% | 8.04% | -43.76% |
| Cash from Operations | 41.83% | 7.34% | -37.72% | -11.35% | -4.65% |
| Capital Expenditure | 51.61% | 60.05% | 86.26% | 91.63% | -665.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 253.66% | -41.00% | -98.84% | -78.04% | -98.64% |
| Cash from Investing | 573.59% | -34.89% | -99.25% | -76.66% | -100.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -26.15% | -16.39% | -77.46% | -99.90% | -45.35% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 252.20% | 2,025.11% | -- | -- | -- |
| Cash from Financing | -58.68% | -67.17% | 48.42% | 55.66% | -43.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -27.56% | -122.60% | -38,339.49% | -6.75% | -108.48% |